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Both acute kidney injury (AKI) and chronic kidney disease (CKD) that lead to diminished kidney function
are interdependent risk factors for increased mortality. If untreated over time, end stage renal disease
(ESRD) is an inevitable outcome. Acute and chronic kidney diseases occur partly due to imbalance be-
tween the molecular mechanisms that govern oxidative stress, inﬂammation, autophagy and cell death.
Oxidative stress refers to the cumulative effects of highly reactive oxidizing molecules that cause cellular
damage. Autophagy removes damaged organelles, protein aggregates and pathogens by recruiting these
substrates into double membrane vesicles called autophagosomes which subsequently fuse with lyso-
somes. Mounting evidence suggests that both oxidative stress and autophagy are signiﬁcantly involved in
kidney health and disease. However, very little is known about the signaling processes that link them.
This review is focused on understanding the role of oxidative stress and autophagy in kidney diseases. In
this review, we also discuss the potential relationships between oxidative stress and autophagy that may
enable the development of better therapeutic intervention to halt the progression of kidney disease and
promote its repair and resolution.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Kidneys are remarkable organs because they perform several
functions essential for healthy living such as regulation of body
ﬂuids and blood pressure, waste products excretion, and produc-
tion of red blood cells. Human kidneys receive approximately 25%
of cardiac output and consume 7% of daily energy expenditure to
support their diverse functions. Kidney diseases pose a worldwide
health problem and lead to signiﬁcant morbidity and mortality
amongst adults, especially older adults. In a recent National Health
interview survey, out of 234,921 adults aged 18 and over, 3882
(approximately 2%) adults reported that in the past 12 months
they had been diagnosed with kidney disease. Kidney diseases are
mainly classiﬁed into two types, either acute kidney injury (AKI) or
chronic kidney disease (CKD). AKI is characterized by sudden andB.V. This is an open access article u
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oi).sometimes fatal loss of kidney function resulting in the accumu-
lation of end products of nitrogen metabolism (urea) and creati-
nine, or decreased urine output, or both [1]. The number of hos-
pital stays associated with AKI has increased from 3942 in 1996 to
23,052 in 2008 [2]. Reduction in kidney function over a period of
time results in chronic kidney disease. CKD is characterized by a
glomerular ﬁltration rate below 60 mls per minute for more than
3 months or urine albumin-to-creatinine ratio over 30 mg of al-
bumin for each gram of creatinine. According to the Center for
Disease Control and Prevention “1 in 10 American adults, more
than 20 million individuals, have some level of chronic kidney
disease” [2]. The prevalence of CKD is increasing most rapidly in
adults 60 years old and above, with the incidence of CKD in-
creasing most rapidly in individuals of age 65 and above [2]. Both
AKI and CKD are closely interconnected syndromes and each dis-
ease serves as a risk factor for the other [3].Autophagy: the basics
Autophagy is a highly dynamic multi-step biological process
that involves breakdown and recycling of intracellular components
and serves as a pro-survival mechanism amongst all eukaryotes
ranging from yeasts to plants to mammals. This process occurs
constitutively at a basal level and acts as a housekeeping me-
chanism to remove damaged or long-lived macromolecules ornder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
A. Sureshbabu et al. / Redox Biology 4 (2015) 208–214 209organelles. However, the implication that autophagy may be
linked to a plethora of human diseases has led to intense interest
in the autophagy ﬁeld over the past decade. In the year 1963,
Christian de Duve was the ﬁrst to coin the term “autophagy” for
the observation of organelle degradation within lysosomes [4].
Nearly after 30 years, the scientiﬁc world has begun to elucidate
the molecular events of autophagy. Autophagy is categorized into
three types: macroautophagy, microautophagy and chaperone
mediated autophagy (CMA). Macroautophagy (hereafter referred
as autophagy) refers to an evolutionarily-conserved lysosomal-
mediated intracellular degradation pathway that is activated in
response to diverse stressful conditions [5]. In microautophagy,
cytosolic components are directly assimilated into the surface
membrane of the lysosome or late endosome through invagina-
tion. In contrast, CMA targets only single proteins in which KFERQ-
motif bearing proteins are identiﬁed by a cytosolic chaperone heat
shock cognate (hsc70) that delivers them to the surface of the
lysosomes for internalization through multimerization of the CMA
receptor protein and lysosomal-associated membrane protein
(LAMP)-2A.Molecular aspects of autophagy
Autophagy proceeds through a series of biochemical reactions
catalyzed by a core set of proteins termed autophagy-related
proteins (Atg). The mechanism of autophagy is best understood in
the context of nutrient starvation. To date, nearly 36 Atg proteins
have been identiﬁed in yeast, and many of their mammalian
homologs have also been identiﬁed [6,7].
The execution of autophagy involves ﬁve major steps (Fig. 1). 1.
The formation of the isolation membrane or phagophore 2. Elon-
gation of the phagophore and cargo recruitment 3. Closure of the
mature autophagosome 4. Fusion between autophagosome and
lysosome 5. Termination or degradation of the autolysosome. The
process of autophagy begins with the formation of an isolation
membrane or phagophore membrane. The phagophore assembly
site (PAS) requires the recruitment of a core set of Atg proteins and
several phosphorylation events (Fig. 1). This process is initiated by
the activation of the Unc-51-like kinase-1 (ULK1)-Atg13-FIP200
complex upon stimulation with metabolic sensors, for example
ATP depletion. At the molecular level, activation of the 5′-Fig. 1. Schematic depiction illustrating the molecular machinery of autophagy with the
components that include the ULK1/2-mAtg13-FIP200 complex are necessary for the in
phosphorylates ULK1/2 and mAtg13 and leads to association and subsequent inhibition
phosphorylation of FIP200, resulting in downstream activation of the autophagy pathwa
enzyme LC3 with phosphatidylethanolamine (PE) to form LC3-PE. ATG5-ATG12-ATG16Ladenosine monophosphate-regulated protein kinase (AMPK)
phosphorylates ULK1/2, which in turn phosphorylates Atg13 and
FIP200 [8]. Recent studies suggest that AMPK-dependent ULK1
phosphorylation regulates the trafﬁcking of mAtg9, a transmem-
brane protein responsible for membrane vesicle delivery to the
PAS [9]. A key report has identiﬁed Atg1, Atg2 and Atg9 as Atg1
kinase substrates in vivo. Furthermore, a recent report also de-
monstrated that Atg1 directly phosphorylates Atg9 essential for
the autophagosome formation, and added this ULK1/Atg1 signal-
ing mechanism to the pathway of autophagy [10]. The ULK1/Atg1
kinase complex, the class III PI3-kinase Beclin1 complex and PI3P
effectors and their related proteins are important for the autop-
hagosome initiation step. A molecular link between ULK1 and the
regulation of the Beclin1 complex through direct phosphorylation
of Vps34 has recently been described [11,12].
Two ubiquitin-like conjugation systems Atg5-12 and the mi-
crotubule-associated protein 1 light chain 3 (LC3)/Atg8 catalyze
the elongation of the phagophore membrane. Ubiquitin-like pro-
tein Atg5 conjugates with Atg12 with the help of E1-like enzyme
Atg7 and E2-like enzyme Atg10 respectively. LC3/Atg8 is processed
by Atg4 to generate the cytosolic LC3-I, which then conjugated to
phosphatidylethanolamine (PE) in a reaction that requires Atg7
and the E2-like enzyme Atg3 respectively. LC3-II remains in-
corporated in the autophagosomal membrane until the autopha-
gosome-lysosome fusion step. During the late stages of autophagy,
LC3B-II associated with the outer autophagosomal membrane is
recycled by Atg4B, whereas LC3B-II at the inner membrane is
degraded by lysosomal activity [13]. Termination is the least well-
studied step of autophagy, but some evidence suggests that mTOR
activity is reactivated after a prolonged period of stress and hence
may regulate the termination step [14]. Further investigations are
required to elucidate the molecular events regulating the termi-
nation process of autophagy.Selective autophagy/mitophagy
Mitophagy is involved in the selective removal of dysfunctional
mitochondria using the autophagy machinery. To date, two types
of mitophagy pathways have been described. Activated PINK1
translocates Parkin from the cytoplasm to defective mitochondria
followed by polyubiquitination of mitochondrial substrates, whichmajor autophagy-related proteins in the autophagy signaling pathway. Molecular
duction of the autophagy pathway. Under a nutrient-rich environment, mTORC1
. During stress or starvation, mTORC1 dephosphorylates ULK1/2 and leads to the
y. E1-like ATG7 and E2-like ATG3 enzymes mediate the lipidation of ubiquitin-like
1 complex and VMP1-ATG9 and LC3-PE systems function in cargo sequestration.
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removal of healthy mitochondria via direct interaction of Nix/
Bnip3 with LC3 [16]. Induction of Parkin-dependent mitophagy
through mitochondrial Reactive Oxygen Species (ROS) has been
reported using a mitochondrial-targeted photosensitizer [17]. In
line with this observation, dynamin-related protein (DRP-1) de-
pendent type of mitophagy can be induced by mild oxidative
stress in both human and mouse cells [15,18]. Both of these reports
suggest that mitochondrial degradation by autophagy and oxida-
tive stress are interrelated.Oxidative stress in kidney diseases
There is general consensus that oxidative stress contributes to
the development of several diseases including AKI and CKD. Oxi-
dative stress occurs when the generation of pro-oxidants or re-
active oxygen species (ROS) exceeds endogenous antioxidant ca-
pacity. Both free radical derivatives (e.g., ROS) and non-radical
derivatives (e.g., H2O2) have the ability to oxidize cellular biomo-
lecules and ultimately leading to cellular demise. The fact that the
kidney organ is rich in mitochondria indicates that it is highly
vulnerable to damage caused by oxidative stress. In kidney, mi-
tochondrial respiratory chain and NADPH oxidases (NOX) are the
major common sources of ROS. To lessen the deleterious effects of
free radicals, antioxidant enzymes such as superoxide dismutase
and catalase have evolved as cellular defenses. It is documented
that ESRD patients have higher rates of pro-oxidant activity and
lower rates of anti-oxidant activity [19,20]. Peroxynitrite (ONOO)
and hydroxyl (OH) radicals are considered highly reactive oxi-
dants as they are capable of extensive modiﬁcation of biomole-
cules including lipids, DNA and proteins [21–23].Oxidative stress in AKI
Oxidative stress is a predominant component involved in the
pathogenesis of AKI. Other components include inﬂammatory re-
sponses and tubular and vascular damage. Ischemia–reperfusion
(I/R) injury and sepsis are two of the most common pathologies
leading to AKI. Numerous studies suggest oxidative stress and its
systemic effects play a pivotal role in the development of AKI. For
example, in a mouse model of renal I/R injury, heme oxygenase-1
knockout (HO-1 /) mice were found to be sensitive to kidney I/R
injury, with subsequent increased kidney injury, inﬂammation and
increased mortality as compared to wild type counterparts [24].
When subjected to kidney ischemic injury, mice deﬁcient in
transient receptor potential cation channel, subfamily M, member
2 (TRPM2) were found to be resistant to oxidative stress and
apoptosis [25]. A recent study demonstrated an increased urinary
thioredoxin 1 (TRX1) expression as an oxidative stress biomarkerTable 1
Drugs and synthetic peptides that modulate oxidative stress-mediated acute and chron
Drug/peptide treatment Injury/disease Effec
Mangiferin Cecal ligation and puncture (CLP)-induced sepsis Inhib
Sialic acid Lipopolysaccharide (LPS)-induced sepsis Redu
Lutein I/R injury Incre
C-type natriuretic peptide I/R injury Inhib
Fluoxetine I/R injury Redu
Celastrol I/R injury Redu
PMVE/MA-SOD & CMC-SOD Diabetes Redu
Curcumin Maleate-induced Nephropathy Preve
Angiotensin [1–7] Diabetic Nephropathy Redu
Febuxostat Diabetic Nephropathy and Albuminuria Preve
activwith respect to I/R-induced renal injury [26]. Moreover, deﬁciency
of CCAAT-enhancer-binding protein homologous protein (CHOP)
prevented oxidative damage and suppressed inﬂammation in re-
nal tubular cells subjected to I/R injury [27].Oxidative stress in CKD
Diabetic nephropathy (DN) is a devastating complication of
diabetes and a major cause of CKD. In DN, early structural changes
consist of glomerular and tubuloepithelial hypertrophy. This is
followed by progressive thickening of the glomerular and tubular
basement membranes, which becomes evident over a period of
years [28]. As with most progressive chronic kidney diseases, tu-
bulointerstitial ﬁbrosis develops in advanced stages of DN. In CKD,
NOX1, NOX2 and NOX4 are all demonstrated to produce oxidative
stress by enhancing vascular dysfunction and ﬁbrosis [29,30]. In-
terestingly, NOX2 and NOX4 expressions were found to be ele-
vated in I/R injury [31]. Moreover, NOX5 expression was found to
be increased in human biopsy specimens from patients diagnosed
with DN [32]. Different drugs and small peptides have been ex-
plored to reduce oxidative stress and ameliorate acute and chronic
kidney diseases (Table 1).Inﬂammation
Inﬂammation is the most common outcome of oxidative stress.
ROS directly or indirectly elevate inﬂammation, and trigger the
expression of pro-inﬂammatory cytokines and chemokines. Al-
though considered an important part of host defense mechanisms,
inﬂammation is excessively activated in many pathological con-
ditions. Oxidative stress is well known to induce inﬂammation and
both processes are deeply interrelated in kidney diseases [33,34].
Pro-inﬂammatory cytokines and chemokines generated by tubular
epithelial cells act as a stress response and a mechanism to un-
dergo repair and restoration. However, unresolved renal in-
ﬂammation results in acute and chronic kidney diseases. Celastrol
treatment has been shown to prevent I/R injury by reducing tub-
ular injury and renal inﬂammation [35]. In the context of systemic
diseases such as sepsis, tubular epithelial cells contribute to the
excessive synthesis and release of inﬂammatory mediators that
ultimately result in injury of local and distant organs.Autophagy in kidney diseases
To date, evidence from numerous studies corroborate that au-
tophagy has an important renoprotective function in tubular epi-
thelial cells and in podocytes [28,36]. Although autophagy plays a
protective role in acute and chronic kidney diseases, furtheric kidney diseases.
ts Reference
its oxidative stress and decreases apoptosis in vitro and in vivo [56]
ces oxidative stress, inﬂammation and apoptosis in rat kidneys [57]
ases antioxidant capacity in rat kidneys [58]
its oxidative stress and apoptosis [59]
ces oxidative stress and inﬂammation [60]
ces inﬂammation and tubular injury [35]
ces oxidative stress [61]
nts oxidative stress and preserves mitochondrial function [62]
ces glucose-induced oxidative stress and cell proliferation [63]
nts oxidative stress and inﬂammation via inhibition of XO and XDH
ities
[64]
Fig. 2. Interplay of redox signaling and autophagy in acute and chronic kidney injury. In general, both acute and chronic kidney injuries increase oxidative stress and
autophagic ﬂux. The proposed mechanism by which oxidative stress contributes to inﬂammation and cell death involves sustained levels of ROS generation. This excessive
oxidative stress, depending upon intensity and/or duration, induces cellular dysfunction and the pathogenesis of AKI and CKD, and ultimately kidney failure and ESRD.
Autophagy protects renal tissue by clearing damaged organelles such as mitochondria and thereby indirectly inhibits excessive ROS production, inﬂammation and cell death.
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ways and consequences of autophagy related to the regulation of
inﬂammation and cell death is required (Fig. 2). Genetically
modiﬁed animal models that are deﬁcient in autophagy pathway
served as valuable tools to advance the understanding of the
function of autophagy in a variety of kidney diseases.Autophagy in AKI
To date, the effects of autophagy in AKI have been studied
mostly in tubular epithelial cells and podocytes. The ﬁrst evidence
came from a renal I/R rat model, where Atg proteins such as Be-
clin1 and LC3 were found increased in proximal and distal epi-
thelial cells. Furthermore, it was shown that augmented expres-
sion of Bcl-XL in the kidney was sufﬁcient to inhibit autophagy
induction and apoptosis [37]. In line with this observation, au-
tophagosomes were identiﬁed in murine renal tubular cells in
response to I/R injury [38]. It was also documented that autop-
hagic ﬂux was increased during the reperfusion period [39]. Si-
milarly, kidney tubule-speciﬁc autophagy deﬁcient mice models
have added more robust conclusions. In response to I/R injury,
tubular cell speciﬁc Atg5 and Atg7 knockout mice displayed dra-
matically increased tissue damage and apoptosis [40,41]. However,
the mechanism by which I/R injury promotes autophagic induc-
tion and its consequences in terms of inﬂammation and cell death
is unclear.
As aforementioned, autophagy was also documented to have a
renoprotective role in response to septic insults. In a rat model of
cecal ligation and puncture (CLP)-induced sepsis, autophagy was
increased in the early stages followed by decline with the later
stages of kidney injury in sepsis. In line with this observation, Atg7
siRNA treatment enhanced tumor necrosis factor-α-induced cell
death in renal tubular cells in vitro [42]. In a recent study, older
mice showed diminished autophagy as compared to younger
counterparts during endotoxemia [43]. Therefore, these data sug-
gest that induction of autophagy protects younger mice whereas
restoration of autophagy protects older mice in sepsis-induced
AKI. Since sepsis is a highly complex pathophysiological disease, itmay be clinically-relevant to target autophagy in combination with
other multiple mechanistic pathways that prove beneﬁcial
therapy.Autophagy in CKD
An emerging body of evidence suggests that autophagy plays a
critical role in chronic kidney diseases. Targeting ﬁbrogenic com-
ponents in tubular epithelial cells and ﬁbroblasts or myoﬁbro-
blasts as a therapeutic approach is currently under active research.
Transforming growth factor-beta 1 (TGF-β1) is the most potent
proﬁbrogenic factor for the development of renal ﬁbrosis [36].
Recently, our group has demonstrated induction of autophagy in
renal tubular epithelial cells of obstructed kidneys after unilateral
ureteral obstruction (UUO), an in vivo experimental model of renal
ﬁbrosis. LC3 knockout mice and Beclin1 heterozygous knockout
mice exhibited increased collagen deposition and increased ma-
ture TGF-β1 levels in obstructed kidneys after UUO. These data
suggest that in renal proximal tubular epithelial cells, mature TGF-
β1 levels are regulated through autophagic degradation, which
suppresses kidney ﬁbrosis induced by UUO [44].
In podocytes, high basal levels of autophagy infer its require-
ment for normal cellular homeostasis [45]. Autophagy-speciﬁc
Atg5 or Atg7 conditional knockout mice exhibited enhanced va-
cuolization in podocytes and tubular cells and ultimately resulted
in Focal Segmental Glomerular Sclerosis (FSGS) and organ failure
[46]. Furthermore, Atg5 deﬁcient proximal tubular epithelial cells
showed enhanced mitochondrial dysfunction and elevated ROS
production [46]. These data suggest that autophagy deﬁciency in
the kidney epithelium can recapitulate the characteristic features
of FSGS observed in the kidneys of patients with idiopathic FSGS.Autophagy and oxidative stress
In the past few years, there is growing consensus that oxidative
stress and autophagy are intricately connected (Fig. 3). It is well
known that basal levels of redox signaling and autophagy
Fig. 3. Diagrammatic representation illustrating the induction of oxidative stress and autophagy leading to normal cell growth or cell death at various levels of stress in the
kidney. Basal levels of redox signaling and autophagy are necessary for the homeostasis. Mild oxidative stress triggers cell survival and repair mechanisms such as the
autophagy pathway. a) Schematic overview of the autophagy pathway b) increased ROS levels above basal values for a prolonged period. In the case of severe oxidative
stress, ROS/RNS levels are excessive for a prolonged period leading to oxidative damage and ultimately cell demise. For example, lysosomal permeabilization occurs due to
excessive ROS levels can contribute to autophagic impairment and autosis.
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mediate cytoprotective mechanisms. Under distinct circumstances,
changes in autophagic ﬂux have been shown to regulate ROS for-
mation and redox signaling. Numerous lines of evidence suggest
that ROS and reactive nitrogen species (RNS) act as upstream
modulators of autophagy induction [47]. In line with this, a few
studies have demonstrated that ROS act as inducers of autophagy
with respect to nutrient deprivation [48]. Therefore, oxidative
stress can affect autophagy and vice-versa. In a key report, p62
dependent degradation of Keap1 has been shown to regulate Nrf2
signaling and protect against oxidative stress [49–51]. However,
there remains a signiﬁcant amount of work that needs to be done
in the ﬁeld of kidney diseases. Although the concepts of oxidative
stress and autophagy have been extensively studied individually,
the emerging links between these processes in kidney diseases
have not been examined in detail.Autophagy and cell death
Another issue to be considered is how autophagy and cell death
are related in kidney diseases. The functional relationship between
autophagy and cell death in renal pathophysiology is somewhat
controversial. Thus far, the majority of evidence suggests that
autophagy functions as a renoprotective process, yet some evi-
dence suggests that autophagy contributes to cell death (Fig. 3).
Although there is much debate on the deﬁnition of autophagic cell
death, the following criteria speciﬁed by the nomenclature com-
mittee on cell death should be met: 1) occurrence of cell death
without caspase activation and chromatin condensation, 2) dying
cells should demonstrate increased autophagic ﬂux, and 3) genetic
blockade of at least two molecules of the autophagy pathway that
can delay or prevent cell death [52,53]. Inhibition of mitochondrialelectron transport chain complexes I and/or II induces autophagic
cell death which is reduced by knockdown of major autophagy
related proteins Atg5, Beclin1 and/or Atg7 in human embryonic
kidney cells [54]. In contrast, a study has reported that inhibition
of autophagy can lead to podocyte apoptosis by activating en-
doplasmic reticulum stress [55].Concluding remarks
Both acute and chronic kidney diseases remain major con-
tributors to morbidity and mortality in hospitalized patients. To
date, limited information is available for understanding the roles
of autophagy and oxidative stress in kidney diseases as interlinked
pathways. This implies that there are important questions that still
need to be answered by the scientiﬁc world. In this regard, for
example, implications of defective redox signaling and autophagy
signaling in kidney diseases remain to be uncovered. Another
important question would be to identify speciﬁc signals that reg-
ulate the molecular interactions between oxidative stress and
autophagy. Therefore, a detailed understanding of the molecular
regulation of oxidative stress by autophagy signaling will answer
key questions about this bilateral relationship in kidney health and
disease. Nevertheless, genetically modiﬁed animal models that are
deﬁcient in oxidative stress-related and autophagy processes may
serve as valuable tools and provide new insights into the me-
chanisms that need to be elucidated. Equally, speciﬁc therapeutic
agents that regulate both oxidative stress signaling and autophagy
signaling are needed. Advances such as these will be likely to
improve therapeutic approaches and hold promise to beneﬁt pa-
tients with kidney diseases.
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